Scientists from the University of Utah and University of Washington have developed blueprints that instruct human cells to assemble a virus-like delivery system that can transport custom cargo from one cell to another. As reported online in Nature on Nov. 30, the research is a step toward a nature-inspired means for delivering therapeutics directly to specific cell types within the body.
“We’re shifting our perception from viruses as pathogens, to viruses as inspiration for new tools,” says Wesley Sundquist, Ph.D., co-chair of the Department of Biochemistry at the University of Utah School of Medicine. He is also co-senior author on the study with Neil King, Ph.D., an assistant professor at the Institute for Protein Design at the University of Washington.
The carefully designed instructions set forth a series of self-propelled events that mimic how some viruses transfer their infectious contents from one cell to the next.
From the blueprints tumbled out self-assembling, soccer ball-shaped “nanocages”, the structure of which was reported previously. Adding on specific pieces of genetic code from viruses caused the nanocages to be packaged within cell membranes, and then exported from cells. Like a shuttle leaving Earth to bring goods to a space station, the tiny capsules undocked from one cell, traveled to another and docked there, emptying its contents upon arrival.
In this case, the protective nanocages carried cargo that the scientists used like homing beacons to track the vessels’ journeys. Next steps are to design nanocages that hold drugs or other small molecules.
“We are now able to accurately and consistently design new proteins with tailor-made structures,” says King. “Given the remarkably sophisticated and varied functions that natural proteins perform, it’s exciting to consider the possibilities that are open to us.”
The researchers’ decision to model the microscopic shipping system after viruses was no accident. Viruses have honed their skills to effectively spread their infectious wares to large numbers of cells. Decades of research, including in-depth investigations of the human immunodeficiency virus (HIV) by Sundquist’s team, have led to an understanding of how the pathogens accomplish this goal with such efficiency.
A test of whether you truly understand something is to build it yourself. And that’s what Sundquist and King’s teams have done here. “The success of our system is the first formal proof that this is how virus budding works,” remarks Sundquist.
Viruses taught them that such a delivery system must include three essential properties: an ability to grasp membranes, self-assemble, and to be released from cells. Introducing coding errors into any one of those steps brought shipments to a halt.
“I was sure that this would need fine-tuning but it was clean from the very beginning,” says lead author Jörg Votteler, Ph.D., a postdoctoral fellow in biochemistry at the University of Utah. When electron microscopist David Belnap, Ph.D. saw that images of the cages aligned closely with computer models, he knew they had made what they set out to design. “When it’s right, you know it,” he says.
The system could be modified as long as the three basic tenets were left intact. For example, the scientists could swap in differently shaped cages, or cause another type of membranes to surround them. Modularity means the vessels can be customized for various applications.
This study is proof of principle that the systems works, but more needs to be done before it can be applied therapeutically. Researchers will need to determine whether the capsules can navigate long journeys within living animals, for instance, and whether they can deliver medicines in sufficient quantities.
“As long as we keep pushing knowledge forward we can guarantee there will be good outcomes, though we can’t guarantee what or when,” says Sundquist.
The Latest on: Virus-like delivery system
via Google News
The Latest on: Virus-like delivery system
- Blavatnik National Awards for Young Scientists announces the finalists of 2021on June 14, 2021 at 9:00 pm
The Blavatnik National Awards today named 31 finalists for the world's largest unrestricted prize honoring early-career scientists. The finalists were culled from 298 nominations by 157 U.S. research ...
- BTN Classroom Episode 17, 2021on June 14, 2021 at 5:00 pm
COVID Variants, Electric Car Class, NASA Venus Missions, Giant Aussie Dinosaur & Blood Donation Day.
- Evolution of a virus-like architecture and packaging mechanism in a repurposed bacterial proteinon June 11, 2021 at 4:45 pm
In addition to evincing a plausible evolutionary pathway for primordial viruses, these findings highlight practical strategies for developing nonviral carriers for diverse vaccine and delivery ...
- Scientists Uncover the Mysteries of How Viruses Evolvedon June 11, 2021 at 12:31 pm
Professor Reidun Twarock, from the University of York's Departments of Mathematics and Biology, and the York Cross-disciplinary Centre for Systems Analysis, said: "Using a novel interdisciplinary ...
- Recreating a step in evolution of viruseson June 11, 2021 at 3:36 am
An international team of researchers has shed new light on the way viruses evolved highly effective ways of spreading disease. The ...
- Understanding evolution of viruseson June 11, 2021 at 1:16 am
Researchers at ETH Zurich have recreated a key step in the evolutionary history of viruses in a laboratory experiment. They succeeded in remodeling ...
- Scientists uncover the mysteries of how viruses evolveon June 10, 2021 at 12:41 pm
The team say their findings have implications for the treatment of viruses in future. Researchers from the Universities of York and Leeds, collaborating with the Hilvert Laboratory at the ETH Zürich, ...
- UK trial for tobacco based Covid vaccine that 'boosts antibodies ten-fold'on June 7, 2021 at 3:55 am
It produces a virus like particle (VLP) that mimics the potentially lethal spike protein that hooks onto cells. The outer structures is the same - making it easily recognised by the immune system.
via Bing News